Percutaneous Mitral Valve Repair versus Optimal Medical Therapy in Patients with Functional Mitral Regurgitation: A Systematic Review and Meta-Analysis

Figure 4

Meta-analysis displaying the risk of 30-day mortality in the PMVR group compared to the OMT group.